1Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and clas- sification of mastocytosis: a consensus proposal [ J ], I,euk Res, 2001, 25 (7) : 603-625.
2Swerdlow S, Campo E, Harris N. et al. World Health Organization classification of turnouts of haematopoietic and lymphoid tissues[ M ]. France: IARC Press,2008:54-63.
3Zermati Y, De Sepulveda P, Feger F, et al. Effect of tyrosine kinase inhibitor ST1571 on the kinase activity of wild-type and various muta- ted c-kit receptors found in mast cell neoplasms [ J ]. Oncogene, 2003, 22(5): 660-664.
4Lim KH, Tefferi A, Lashn TL, et al. Systemic mastocytosis in 342 consecutive aduhs: survival studies and prognostic factors [ J ], Blood, 2009, 113 (23) : 5727-5736.
5Valent P, Sperr WR, Akin C. How I treat patients with advanced sys- temic mastocytosis[Jl. Blood, 2010, 116 (26): 5812-5817.
6Horny HP, Ruck M, Wehrmann M, et al. Blood findings in general- ized mastocytosis : evidence of frequent simuhaneous occurrence of my- eloproliferative disorders[J]. Br J Haematol, 1990,76 (2) : 186-193.
